Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Measurements of dopamine D1-type receptors using simultaneous PET-MRI scanner: Study on test-retest reliability

Simon Kaller, Michael Rullmann, Julia Luthardt, Johanna Girbardt, Philipp Meyer, Peter Werner, Swen Hesse, Thomas Fritz and Osama Sabri
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1795;
Simon Kaller
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Rullmann
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Luthardt
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Girbardt
2Neurology Saxonian Hospital Altscherbitz Schkeuditz Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Meyer
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Werner
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swen Hesse
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
4IFB Adiposity Diseases University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Fritz
1Max Planck Institute for Human Cognitive and Brain Sciences Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osama Sabri
4IFB Adiposity Diseases University of Leipzig Leipzig Germany
3Department of Nuclear Medicine University of Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1795

Objectives The role of dopamine D1-type receptor (D1R)-expressing neurons in the regulation of motivated behavior and future reward prediction remains elusive. In order to assess D1-mediated neuronal network regulation using truly simultaneous PET-MRI and D1R-selective [11C]SCH23390, the aim of this study was to calculate the stability of D1R-binding potential (BPnd) intra-individually in the brain between two independent PET-MRI measurements under neutral conditions.

Methods Fifteen healthy volunteers (7 females, aged 33 ± 13yrs) underwent two 90-min emission scans each after 90-sec bolus infusion of 486 ± 16MBq [11C]SCH23390 on two separate days within 2 weeks (scan1 and scan2) using mMR biograph (SIEMENS). For attenuation correction (AC), a two-point MRI Dixon VIBE sequence was obtained in parallel to the PET acquisition, resulting in segmented AC maps. After performing motion correction with SPM8, the parametric images of D1R BPnd were generated in PMOD3.2 (PMOD Technologies, Zurich, Switzerland) by multi-linear reference tissue model with two parameters with the cerebellar cortex as receptor free reference region. For VOI-analysis, BPnd data were then co-registered with the individual spatially reoriented T1 MRI data (PMOD3.2) and target VOIs were manually drawn on consecutive transversal MRI slices. SPM8 was used for voxel-wise comparison with spatially normalized BPnd images. For group comparison scan1 vs scan2 a paired t-test was applied, which was considered significant at p<0.05 (VOI-based) and p<0.005 (uncorrected with minimum cluster size of 30 voxels for SPM).

Results Neither voxel-wise nor VOI-based analyses revealed significant differences in BPnd between the two measurements with calculated BPnd of 1.47 ± 0.30 (scan1) and 1.45 ± 0.31 (scan2) for the nucleus accumbens; 1.90 ± 0.39 (scan1) and 1.91 ± 0.56 (scan2) for the head of the caudate; 1.57 ± 0.44 (scan1) and 1.58 ± 0.53 (scan2) for the putamen; 0.36 ± 0.13 (scan1) and 0.36 ± 0.13 (scan2) for the dorsolateral prefrontal cortex; and 0.29 ± 0.09 (scan1) and 0.28 ± 0.09 (scan2) for the substantia nigra/ventral tegmental area. This resulted in absolute variabilities (%) of 8.1 ± 6.7; 8.1 ± 7.2; 8.5 ± 8.0; 13.5 ± 13.3; and 14.8 ± 14.3. Mean differences according to Bland-Altman analyses were very low (0.013 ± 0.17; -0.011 ± 0.24; -0.013 ± 0.23; 0.003 ± 0.05; and 0.011 ± 0.05, respectively) and intraclass correlation (one-way, random) indicated very high agreement (0.93; 0.92; 0.95; 0.97; and 0.93).

Conclusions Test-retest reliability of D1R measurements using [11C]SCH3390 and simultaneous PET-MRI is high not only in D1R-rich brain areas but also in areas with lower D1R content. These measurements will provide the base for future multimodal joint PET-MRI data analyses in stimulation-dependent mapping of D1R-containing neurons and their effects on neuronal circuits determining behavior.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Measurements of dopamine D1-type receptors using simultaneous PET-MRI scanner: Study on test-retest reliability
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Measurements of dopamine D1-type receptors using simultaneous PET-MRI scanner: Study on test-retest reliability
Simon Kaller, Michael Rullmann, Julia Luthardt, Johanna Girbardt, Philipp Meyer, Peter Werner, Swen Hesse, Thomas Fritz, Osama Sabri
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1795;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Measurements of dopamine D1-type receptors using simultaneous PET-MRI scanner: Study on test-retest reliability
Simon Kaller, Michael Rullmann, Julia Luthardt, Johanna Girbardt, Philipp Meyer, Peter Werner, Swen Hesse, Thomas Fritz, Osama Sabri
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1795;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

MTA II: Basic Science Posters

  • Effect of Serotonin-Specific Antidepressant on Radiolabeled Metaiodobenzylguanidine (MIBG) Uptake
  • A novel quantification of 99mTc-MDP concentration and 18F-FDG PET/CT metabolism in lumbar disc herniation patients
  • In vivo study of a PET radiotracer for imaging P2X7 receptors for neuroinflammation in animal model
Show more MTA II: Basic Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire